Placental gene expression of the placental growth factor (PlGF) in intrauterine growth restriction

References

• Wollmann HA. Intrauterine growth restriction: definition and etiology. Horm Res 1988;49:1–6
   Google Scholar
• Sheikh S, Satoskar P, Bhartiya D. Expression of insulin-like growth factor-I and placental growth hormone mRNA in placentae: a comparison between normal and intrauterine growth retardation pregnancies. Mol Hum Reprod 2001;7:287–92
   PubMed Web of Science ®Google Scholar
• Gluckman PD, Harding JE. The physiology and pathophysiology of intrauterine growth retardation. Horm Res 1997;48:11–6
   PubMed Web of Science ®Google Scholar
• Börzsönyi B, Demendi C, Nagy Z, et al. Gene expression patterns of insulin-like growth factor 1, insulin-like growth factor 2 and insulin-like growth factor binding protein 3 in human placenta from pregnancies with intrauterine growth restriction. J Perinat Med 2011;39:701–7
   PubMed Web of Science ®Google Scholar
• Demendi C, Börzsönyi B, Nagy ZB, et al. Gene expression patterns of insulin-like growth factor 1, 2 (IGF-1, IGF-2) and insulin-like growth factor binding protein 3 (IGFBP-3) in human placenta from preterm deliveries: influence of additional factors. Eur J Obstet Gynecol Reprod Biol 2012;160:40–4
   PubMed Web of Science ®Google Scholar
• Szentpéteri I, Rab A, Kornya L, et al. Gene expression patterns of vascular endothelial growth factor (VEGF-A) in human placenta from pregnancies with intrauterine growth restriction. J Matern Fetal Neonatal Med 2013;26:984–9
   PubMed Web of Science ®Google Scholar
• Rab A, Szentpéteri I, Kornya L, et al. Placental gene expression patterns of epidermal growth factor in intrauterine growth restriction. Eur J Obstet Gynecol Reprod Biol 2013. 170:96–9
   PubMed Web of Science ®Google Scholar
• Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167–71
   PubMed Web of Science ®Google Scholar
• Maglione D, Guerriero V, Viglietto G, et al. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 1993;8:925–31
   PubMed Web of Science ®Google Scholar
• Torry DS, Hinrichs M, Torry RJ. Determinants of placental vascularity. Am J Reprod Immunol 2004;51:257–68
   PubMed Web of Science ®Google Scholar
• Cowans NJ, Stamatopoulou A, Matwejew E, et al. First-trimester placental growth factor as a marker for hypertensive disorders and SGA. Prenat Diagn 2010;30:565–70
   PubMed Web of Science ®Google Scholar
• Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159–67
   PubMed Web of Science ®Google Scholar
• Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001;357:209–15
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99
   PubMed Web of Science ®Google Scholar
• Benton SJ, Yuxiang H, Fang X, et al. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction. Am J Obstet Gynecol 2011;205:e1–e8
   Google Scholar
• Engineer N, Kumar S. Perinatal variables and neonatal outcomes in severely growth restricted preterm fetuses. Acta Obstet Gynecol Scand 2010;89:1174–81
   PubMed Web of Science ®Google Scholar
• Roberts D, Post M. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol 2008;61:1254–60
   PubMed Web of Science ®Google Scholar
• Khong T, de Wolf F, Robertson W, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestationakl age infants. Br J Obstet Gynecol 1986;93:1049–59
   PubMedGoogle Scholar
• Clark D, Smith S, Licence D, et al. Comparison of expression patterns for placental growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol 1998;159:459–67
   PubMed Web of Science ®Google Scholar
• Makrydimas G, Sotiriadis A, Savvidou M, et al. Physiological distribution of placental growth factor and soluble Flt-1 in early pregnancy. Prenat Diagn 2008;28:175–9
   PubMed Web of Science ®Google Scholar
• Levine R, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992–1005
   PubMed Web of Science ®Google Scholar
• Romero R, Nien J, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop praeeclampsia and deliver a small for gestational age neonate. J Matern Fet Neonat Med 2008;21:9–23
   PubMed Web of Science ®Google Scholar
• Taylor R, Grimwood J, Mcmaster M, et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathological pregnancies. Am J Obstet Gynecol 2003;188:177–82
   PubMed Web of Science ®Google Scholar
• Poon LC, Zaragoza E, Akolekar R, et al. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn 2008;28:1110–5
   PubMed Web of Science ®Google Scholar
• Gomez-Roig DM, Mazarico E, Sabria J, et al. Use of placental growth factor and uterine artery Doppler pulsatility index in pregnancies involving intrauterine fetal growth restriction or preeclampsia to predict preinatal outcomes. Gynecol Obstet Invest 2015;80:99–105
   PubMed Web of Science ®Google Scholar